RITONAVIR 100 MG TABLET

ritonavir 100 mg
$0.6367per EA

Strength

100 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097065502

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

RITONAVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA202573

On Market Since

3/23/2022

Pharmacological Classes

Breast Cancer Resistance Protein Inhibitors
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inducers
Cytochrome P450 3A Inhibitor
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
HIV Protease Inhibitors
P-Glycoprotein Inhibitors
Protease Inhibitor
UDP Glucuronosyltransferases Inducers

Price History

1W

0.0%

1M

-2.4%

3M

-17.0%

6M

-22.6%

1Y

-28.2%

3Y

-40.7%

5Y

N/A

All

-36.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.